MAJOR $$ MARGIN IMPROVEMENT $$ Reminder 2 Floair Aerosol Inhalers & RexAir Aerosol Inhalers
Click here to access the analysis for Fluticasone Inhalers.
Click here to access the analysis for Fluticasone with salmeterol Inhalers.
As per our Mind Time notification of 23 October 2019, PHARMAC have confirmed the awarding of sole supply for Fluticasone to Flixotide and Fluticasone with salmeterol to Seretide effective from 1 September 2020.
(Please note price decreases applying to Flixotide Inhalers 50 mcg and 250 mcg, Seretide Inhalers with salmeterol 50 mcg and 125 mcg effective 1 March 2020. ProPharma / PWR will reduce the price to pharmacy effective 12 February 2020)
This provides you with potentially your last opportunity to improve your $$ margin on Floair and RexAir inhalers.
Rex Medical have offered an improved discount structure from 1 November 2019 until 31 August 2020 or stocks are depleted, whichever comes first.
No credits will be transacted for Floair or Rexair inhalers.
We ask that you continue to order the incumbent (Rex Medical) product for as long as possible. This will assist all three parts of the supply chain (Manufacturer, Wholesale and Pharmacy) to move the stock through the system.
ProPharma/PWR will implement automatic replacement no later than 31 August 2020
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.